Literature DB >> 26088190

Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant.

Waleska Modesto1, Natália Dal Ava2, Ilza Monteiro2, Luis Bahamondes2.   

Abstract

PURPOSE: There is scarce information about bone mineral density (BMD) and body composition (BC) among users of the etonogestrel (ENG)-releasing implant. AIMS: To evaluate BC and BMD in ENG-releasing implant users as compared to copper intrauterine device (Cu-IUD)-users.
METHODS: A prospective study was conducted on 75 users of both contraceptive methods. BMD was evaluated at femoral neck (FN) and lumbar spine (LS) (L1-L4) and BC at baseline and at 12 months after insertion.
RESULTS: The mean (±SD) age was 30.4 ± 6.8 and 29.8 ± 8.4 years and body mass index (kg/m(2)) was 24.9 ± 4.1 and 24.6 ± 3.5 in ENG-releasing implant- and Cu-IUD-users, respectively. ENG-releasing implant users did not show significant differences on BMD at the LS and FN at 12 months of use. Furthermore, ENG-implant users had an increase in body weight at 12 months (p < 0.001) and an increase of 2 % in the percentage of body fat, when compared with Cu-IUD users. There was a significant increase in lean mass in ENG-implant users at 12 months (p = 0.020).
CONCLUSIONS: No significant changes of BMD were seen after the first year of use among the ENG-releasing implant-users, albeit an increase of weight and fat mass was seen when compared to Cu-IUD users.

Entities:  

Keywords:  Body composition; Bone mineral density; Etonogestrel-releasing implant

Mesh:

Substances:

Year:  2015        PMID: 26088190     DOI: 10.1007/s00404-015-3784-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  10 in total

Review 1.  Contraceptive Considerations for Women with Gastrointestinal Disorders.

Authors:  Aparna Sridhar; Carrie A Cwiak; Andrew M Kaunitz; Rebecca H Allen
Journal:  Dig Dis Sci       Date:  2016-11-24       Impact factor: 3.199

2.  An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users.

Authors:  Aaron Lazorwitz; Eva Dindinger; Margaret Harrison; Christina L Aquilante; Jeanelle Sheeder; Stephanie Teal
Journal:  Contraception       Date:  2020-05-12       Impact factor: 3.375

3.  Etonogestrel implant effectiveness.

Authors:  Nicolas Dugré; Nidhi Choksi; Jessica Kirkwood
Journal:  Can Fam Physician       Date:  2022-08       Impact factor: 3.025

4.  Change of contraceptive preference after the free-LARC program for Thai teenagers.

Authors:  Sathaphone Inthavong; Tawiwan Pantasri; Nuntana Morakote; Tanarat Muangmool; Wirawit Piyamongkol; Saipin Pongsatha; Somsak Chaovisitseree
Journal:  BMC Womens Health       Date:  2022-06-07       Impact factor: 2.742

5.  Changes in body composition in women using long-acting reversible contraception.

Authors:  Priscilla de Nazaré Silva Dos Santos; Tessa Madden; Karen Omvig; Jeffrey F Peipert
Journal:  Contraception       Date:  2016-12-30       Impact factor: 3.375

6.  A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.

Authors:  Kusum V Moray; Himanshu Chaurasia; Oshima Sachin; Beena Joshi
Journal:  Reprod Health       Date:  2021-01-06       Impact factor: 3.223

7.  Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.

Authors:  Rossella Attini; Gianfranca Cabiddu; Benedetta Montersino; Linda Gammaro; Giuseppe Gernone; Gabriella Moroni; Domenico Santoro; Donatella Spotti; Bianca Masturzo; Isabella Bianca Gazzani; Guido Menato; Valentina Donvito; Anna Maria Paoletti; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2020-03-12       Impact factor: 3.902

Review 8.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08

Review 9.  Bone health in estrogen-free contraception.

Authors:  P Hadji; E Colli; P-A Regidor
Journal:  Osteoporos Int       Date:  2019-08-24       Impact factor: 4.507

10.  Contraceptive Options Following Gestational Diabetes: Current Perspectives.

Authors:  Ashley M Turner; Emily A Donelan; Jessica W Kiley
Journal:  Open Access J Contracept       Date:  2019-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.